Cost Analysis of PET/CT Versus CT as Surveillance for Stage III Non-Small-Cell Lung Cancer After Definitive Radiation Therapy.

Charissa R Kim,Bumyang Kim,Matthew S Ning,Jay P Reddy,Zhongxing Liao,Chad Tang,James W Welsh,Frank E Mott,Ya-Chen Tina Shih,Daniel R Gomez

Clinical Lung Cancer（2018）

引用 4|浏览7

暂无评分

摘要

Use of PET/CT was associated with higher costs for 18 months after treatment, but the difference was at the borderline of statistical significance at 24 months.

查看译文

关键词

Benefit,Clinical cost,Non–small-cell lung carcinoma,Radiotherapy,Recurrence

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要